ENOB - Enochian Biosciences Inc
Close
0.7
0 0%
Share volume: 88,381
Last Updated: Fri 04 Aug 2023 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.70
0.00
0.00%
Summary score
30%
Profitability
27%
Dept financing
6%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
17.03%
Return on assets
-37.08%
Return on sales
-274995.9%
Return on invested capital
22.27%
Total debt ratio
124.98%
Debt ratio change over timeo
-0.51%
Current Ratio
6.37%
Quick Ratio
0%
Cash Position Ratio
6.19%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-5%
Return on assets
-2.59%
Return on sales
0%
Return on invested capital
-4.68%
Total debt ratio
13.83%
Debt ratio change over timeo
-6.34%
Current Ratio
12.58%
Quick Ratio
0%
Cash Position Ratio
12.44%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-3.27%
Return on assets
-2.75%
Return on sales
0%
Return on invested capital
-2.99%
Total debt ratio
14.97%
Debt ratio change over time
-2.32%
Current Ratio
6.92%
Quick Ratio
0%
Cash Position Ratio
6.76%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-4.29%
Return on assets
-140.45%
Return on sales
0%
Return on invested capital
93.64%
Total debt ratio
-50.84%
Debt ratio change over time
-0.51%
Current Ratio
-166.26%
Quick Ratio
0%
Cash Position Ratio
-165.26%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ENOB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 17.03% | 0% | 0% | 38.79% |
| Return on assets | -37.08% | 0% | 0% | -7.72% |
| Return on sales | -274995.9% | 0% | 0% | -289.72% |
| Return on invested capital | 22.27% | 0% | 0% | 28.64% |
| Profitability | 30% | 0% | 50% | 50% |
| Total debt ratio | 124.98% | 0% | 0% | 227.35% |
| Debt ratio change over time | -0.51% | 0% | 0% | 28.42% |
| Dept financing | 14% | 0% | 0% | 50% |
| Current Ratio | 12.58% | 0% | 0% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 5.11% |
| Cash Position Ratio | 12.44% | 0% | 0% | 4.9% |
| Liquididy | 50% | 0% | 0% | 50% |
| Short-term ratios | ENOB | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -5% | 0% | 0% | 99.58% |
| Return on assets | -2.59% | 0% | 0% | -9.71% |
| Return on sales | 0% | 0% | 0% | -396.4% |
| Return on invested capital | -4.68% | 0% | 0% | 53.38% |
| Profitability | 25% | 0% | 25% | 50% |
| Total debt ratio | 13.83% | 0% | 0% | 120.81% |
| Debt ratio change over time | -6.34% | 0% | 0% | 1.22% |
| Dept financing | 3% | 0% | 0% | 50% |
| Current Ratio | 12.58% | 0% | 0% | 5.11% |
| Quick Ratio | 0% | 0% | 0% | 5.11% |
| Cash Position Ratio | 12.44% | 0% | 0% | 4.9% |
| Liquididy | 50% | 0% | 0% | 45% |